Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: A clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy

American Journal of Surgical Pathology

Volumn 27, Issue 9, 2003, Pages 1197-1202

  Li, Ling Xi L ^a,b   Scolyer, Richard A ^a   Ka, Vivian S K ^a   McKinnon, J Gregory ^a   Shaw, Helen M ^a,b   McCarthy, Stanley W ^a   Thompson, John F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

False negative; Lymph node; Melanoma; Occult metastasis; Pathology; Regional recurrence; Sentinel lymph node; Sentinel node

Indexed keywords

MELAN A; PROTEIN S 100;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MALE; MELANOMA; OCCULT CANCER; REVIEW; SENTINEL LYMPH NODE; TECHNIQUE; TISSUE SECTION; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; S100 PROTEINS; SENTINEL LYMPH NODE BIOPSY; STAINING AND LABELING;

EID: 0042388428     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200309000-00002     Document Type: Review

References (24)

1. Baisden BL, Askin FB, Lange JR, et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol. 2000;24:1140-6.
2. Bostick PJ, Morton DL, Tumer RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999;17:3238-44.
3. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol. 2000;7:469-74.
4. Cochran AJ, Surgical pathology remains pivotal in the evaluation of'sentinel' lymph nodes. Am J Surg Pathol. 1999;23:1169-72.
5. Cochran AJ. The pathologist's role in sentinel lymph node evaluation. Semin Nucl Med. 2000;30:11-7.
6. Cochran AJ, Essner R, Rose DM, et al. Principles of sentinel lymph node identification: background and clinical implications. Langenbecks Arch Surg. 2000;385:252-60.
7. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: an immunohistological study. Am J Surg Pathol. 1988;12:612-8.
8. Cochran AJ, Wen DR, Morton DL. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg. 1992;16:214-21.
9. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999; 134: 381-7.
10. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253-60.
11. Gershenwald JE, Thompson W, Mansfield PE, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-83.
12. Gibbs JF, Huang PP, Zhang PJ, et al. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol. 1999;6:699-704.
13. McCarthy WH, Shaw HM, Cascinelli N, et al. Elective lymph node dissection for melanoma: two perspectives. World J Surg. 1992; 16:203-13.
14. Messina JL, Glass LF. Pathologic examination of the sentinel lymph node. J Fla Med Assoc. 1997;84:153-6.
15. Messina JL, Glass LF, Cruse CW, et al. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol. 1999;23: 686-90.
16. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999;230:453-63.
17. Shidham VB, Qi DY, Acker S, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol. 2001;25:1039-46.
18. Stadelmann WK, Rapaport DP, Soong S-J. Prognostic clinical and pathological features. In: Balch CM, Houghton AN, Sober AJ, et al, eds. Cutaneous Melanoma. St. Louis, MO: Quality, 1998:11-35.
19. Taback B, Morton DL, O'Day SJ, et al. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma. Rec Results Cancer Res. 2001;158:78-92.
20. Thompson JF. Sentinel node biopsy. J Surg Oncol. 1997;66:270-2.
21. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255-60.
22. Thompson JF, Niewind P, Uren RF, et al. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res. 1997;7:500-6.
23. Urist MM, Maddox WA, Kennedy JE, et al. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer. 1983;51:2152-6.
24. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999;86:617-27.